Canadian billionaire Stephen Smith buys 27% stake in the Economist

Stephen Smith's Smith Financial has agreed to acquire a 26.9% minority stake in the Economist Group from Lady Lynn Forester de Rothschild and related parties for an undisclosed sum, subject to approval by TEG’s independent trustees and board. TEG reported revenue of £369m and profit of £48m for the year to March 2025, with subscribers rising 3% to 1.25m; Exor remains the largest shareholder with a 43.4% stake. Smith (Forbes net worth ~$7bn) chairs Glass Lewis and the investment is presented as supportive of editorial independence, while TEG ownership rules cap any single shareholder at 20% of voting rights.

Analysis

The new minority investor materially raises the probability of governance-driven strategic activity without changing day-to-day editorial operations; that dynamic is a catalyst for M&A and portfolio-level thinking across high-margin subscription media and business-intelligence businesses. Because trustees legally limit voting concentration, expect influence to be exerted via board negotiations, commercial partnerships and deal origination rather than rapid control transactions — a multi-quarter process that favors firms able to monetize subscriber growth and cross-sell intelligence products.

Second-order winners are specialist BI and premium subscription publishers that can scale digital ARPU (1–3% organic subscriber growth lifts FCF by high single digits annually at existing margins). Conversely, ad-reliant local publishers and commodity content distributors face widening funding and valuation gaps; capital will rotate toward predictable recurring-revenue models, compressing multiples on the losers and inflating multiples on winners by roughly 1–2x EBITDA over 6–24 months in stressed scenarios.

Key conditional risks: the trustees’ review is the near-term gating item (days–weeks for process, quarters for outcomes); regulatory or reputational scrutiny around the investor’s proxy-advisory ties could delay approvals and create headline-driven 10–20% swings. A reversal would occur if trustees demand structural limits (e.g., governance covenants) or if subscriber surveys show >2–3% churn tied to perceived editorial influence — both would blunt M&A optionality and re-rate the story lower.

Key Decisions for Investors

• Long EXOR (EXO.MI) — 12–24 month horizon. Buy a 3–5% portfolio position sized for idiosyncratic governance upside; thesis: consolidation optionality and benign continuity could re-rate partial holdings by 25–40%. Risk: trustees block meaningful influence or push-heavy dilution; stop-loss at 20% of entry.
• Pair trade: Long New York Times (NYT) / Short Gannett (GCI) — 6–12 month horizon. Long NYT to capture subscription multiple expansion (target +25%); short GCI to capture ad-revenue compression (target -20%). Size equalized by beta; use 3:1 reward:risk on options overlay (buy NYT calls, buy GCI puts) to limit downside.
• Long RELX (REL.L) — 9–18 month horizon. RELX benefits from corporate BI consolidation and higher willingness-to-pay for trusted data; establish a 2–4% position with target upside 20–30% on multiple expansion. Risk: macro capex pullback; hedge with modest short in cyclical info services if GDP indicators roll over.
• Event hedge: Buy put protection (3–6 month expiries) on exposed ad-dependent publishers (e.g., GCI) ahead of trustee decisions. This caps downside from headline risk (10–20%) while retaining upside from broader sector re-rating if approvals complete favorably.